Transcode Therapeutics, Inc. - 8-K Filing
Transcode Therapeutics stockholders approved conversion of preferred shares to common stock, director elections, equity plan amendment, and other proposals at its annual meeting on July 20, 2026. (Items: 5.07 Submission of Matters to a Vote of Security Holders)
Tickers: $RNAZ